Cellular and Molecular Immunotherapy in Neuroinfectious Diseases
This session will highlight cutting-edge research on cellular and molecular immunotherapy approaches for neuroinfectious diseases. Researchers are encouraged to submit abstracts on novel therapies, mechanisms of action, and clinical outcomes. Attendees will gain a deep understanding of the potential of immunotherapy to transform the treatment landscape for neuroinfectious diseases.
Related Conference of Cellular and Molecular Immunotherapy in Neuroinfectious Diseases
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Cellular and Molecular Immunotherapy in Neuroinfectious Diseases Conference Speakers
Recommended Sessions
- Neuroinflammation and Psychiatric Disorders
- Advances in Immunotherapy for Neuroimmune Disorders
- Artificial Intelligence in Neuroimmunology Research
- Autoimmunity in Neurodegenerative Diseases
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases
- Emerging Viral Neuroinfections
- Gene Editing and Neuroimmune Disorders
- Genomics and Precision Medicine in Neuroimmunology
- Immunometabolism in Neuroinflammation
- Innate Immunity in Neurological Diseases
- Molecular Pathways in Neuroimmune Disorders
- Neuroimmune Biomarkers: From Discovery to Clinical Application
- Neuroimmune Mechanisms in CNS Infections
- Neuroimmune Responses to Environmental Triggers
- Neuroimmunology of Aging and Neurodegeneration
- Neuroimmunology of Pain and Neuropathic Conditions
- Neuroinfectious Disease Epidemiology
- Role of Microglia in Neuroimmunology
- The Blood-Brain Barrier in Health and Disease
- The Microbiome-Neuroimmune Connection
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)